The Association of British HealthTech Industries (ABHI) has announced that more space is now available for UK companies to showcase their cutting-edge products and services at Arab Health 2024.
Arab Health 2023 attracted a record number of professionals, with 135,880 visitors from 183 countries alongside 3,358 exhibitors.
The ABHI UK Pavilion at Arab Health 2023 also reported its most successful year to date, showcasing the exceptional demand and interest in UK health tech.
With over 80 per cent of exhibitors rebooking on the spot, there is a great anticipation for next year’s edition, with a strong UK delegation already committed to attending.
Now, the ABHI UK Pavilion is offering more space, allowing more UK companies to participate in the nation’s largest Pavilion of health tech companies.
By joining the ABHI UK Pavilion, exhibitors gain access to brand alignment with the UK’s leading health tech Trade Association, enabling them to leverage high-quality support to refine their global strategy.
Michelle Michelucci, Head of International Events, ABHI said: “We are extremely proud of the resounding success of the ABHI UK Pavilion at Arab Health 2023.
“The overwhelming support from our exhibitors underscores the high demand for UK health tech innovations and the significance of Arab Health as a platform for international collaboration and business growth.
“We are excited to offer even more spaces on the ABHI UK Pavilion for Arab Health 2024, enabling us to accommodate the show’s growth and welcome an increased number of UK companies to showcase their groundbreaking solutions on the global stage.”
The ABHI UK Pavilion offers the chance for UK companies to showcase their innovative solutions, build international partnerships, and explore new business opportunities in the Middle East.
Together, the delegation will demonstrate the strengths of UK health tech to a global audience of over 136,000, giving visitors a chance to see cutting-edge technologies and the latest product launches.
The Pavilion will highlight how UK technology and expertise can help solve some of the biggest challenges facing healthcare today.
Companies joining ABHI will be a part of the UK’s most visible pavilion of health tech companies, whilst benefiting from a comprehensive exhibition package, complimentary PR and in-market support, alongside a host of exclusive benefits before, during and after the exhibition.
In addition, all exhibitors will be featured in the second edition of the UK Healthcare Pavilion Magazine.
The dedicated brochure includes a full exhibitor directory, as well as articles and features that capture the UK’s world-class health tech offerings.
The magazine will be available to all visitors of the ABHI UK Pavilion at Arab Health and distributed electronically to thousands of people.
With spaces filling up rapidly, UK companies interested in joining the ABHI UK Pavilion at Arab Health 2024 are encouraged to book their stand now to secure their preferred location.
For more information, visit: https://ukhealthcarepavilion.com/events/arab-health-2024/
TheHill secures UK gov funding and Barclays support to help advance digital innovation
Real time data collection changes the game for the stroke patient pathway
Inside BT’s mission to boost NHS connectivity
UCB and Open Medical partnership will support Fracture Liaison Services
Radar Healthcare announces Aamal Medical partnership
Photodisinfectant: can light curb the antimicrobial resistance crisis?
Video games may help teens discuss mental health
Why it’s time to revisit workplace mental health initiatives and make them work for everyone
Innovations in self-diagnostics technology: Paving the way to a healthier future?
Telehealth solution revolutionising stroke care in Cardiff and Vale UHB
- Medtech4 weeks ago
Surgical Holdings to attend MEDICA to highlight how distributors can achieve greater sustainability
- Leadership3 weeks ago
Four steps to improving primary care
- Events5 days ago
Online event to help healthcare professionals with business support
- Life sciences4 weeks ago
AI identifies potential gonorrhoea vaccine proteins